Nonetheless, the osteoporosis model employed in that study was aged mice, and further exploration of the role of FABP3 in postmenopausal osteoporosis, specifically concerning primary osteoporosis after menopause, requires comprehensive validation in human MSCs and OVX-induced mouse models to determine the potential upstream mechanisms involved in postmenopausal osteoporosis. The gene discussed is FABP3; the disease is postmenopausal osteoporosis.